The proposed Mid-Career Investigator Award in Patient-Oriented Research (K24) includes a program of career development training, research in pediatric psychopharmacology, and research mentoring of young investigators. A major focus of the project is to acquire additional research skills with which to better identify possible predictors of therapeutic drug response and adverse reactions to psychotropics used in the treatment of childhood neuropsychiatric illnesses. The research project proposes additional analyses of potential predictor variables from the candidate's involvement in the multi-site NIMH Research Units on Pediatric Psychopharmacology (RUPP) Autism Risperidone Study. Predictor variables relating to the serotonin system and drug metabolism will be explored, with the goal of generating hypotheses to be replicated in other samples. The candidate is a mid-level faculty member with a track record of researching the neurobiology of neuropsychiatric disorders in children and adolescents, who has evolved to have an increasing focus on pediatric psychopharmacology. The additional career training plan includes courses in biostatistics, genetics, and neuropharmacology. The didactic coursework is augmented by extramural coursework, laboratory training, and tutoring with faculty in the UCLA School of Medicine. The proposed training experience dovetails with the candidate's ongoing research involvement enabling an integration of training goals with research application. The candidate proposes to continue and expand ongoing mentoring activities of research trainees and junior faculty. The support from the proposed Mid-Career Award would significantly enhance the candidate's research background and enable a redoubled effort in his research and mentoring activities.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Midcareer Investigator Award in Patient-Oriented Research (K24)
Project #
5K24MH001805-05
Application #
6937750
Study Section
Special Emphasis Panel (ZRG1-BDCN-5 (01))
Program Officer
Gilotty, Lisa
Project Start
2001-08-14
Project End
2006-06-30
Budget Start
2005-07-01
Budget End
2006-06-30
Support Year
5
Fiscal Year
2005
Total Cost
$132,328
Indirect Cost
Name
University of California Los Angeles
Department
Psychiatry
Type
Schools of Medicine
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Criado, Kristen K; Sharp, William G; McCracken, Courtney E et al. (2017) Overweight and obese status in children with autism spectrum disorder and disruptive behavior. Autism :1362361316683888
Scahill, Lawrence; Bearss, Karen; Sarhangian, Rena et al. (2017) Using a Patient-Centered Outcome Measure to Test Methylphenidate Versus Placebo in Children with Autism Spectrum Disorder. J Child Adolesc Psychopharmacol 27:125-131
Aman, Michael; Rettiganti, Mallikarjuna; Nagaraja, Haikady N et al. (2015) Tolerability, Safety, and Benefits of Risperidone in Children and Adolescents with Autism: 21-Month Follow-up After 8-Week Placebo-Controlled Trial. J Child Adolesc Psychopharmacol 25:482-93
McCracken, J T; Badashova, K K; Posey, D J et al. (2014) Positive effects of methylphenidate on hyperactivity are moderated by monoaminergic gene variants in children with autism spectrum disorders. Pharmacogenomics J 14:295-302
Scahill, Lawrence; Hallett, Victoria; Aman, Michael G et al. (2013) Brief Report: social disability in autism spectrum disorder: results from Research Units on Pediatric Psychopharmacology (RUPP) Autism Network trials. J Autism Dev Disord 43:739-46
Tobiasova, Zuzana; van der Lingen, Klaas H B; Scahill, Lawrence et al. (2011) Risperidone-related improvement of irritability in children with autism is not associated with changes in serum of epidermal growth factor and interleukin-13. J Child Adolesc Psychopharmacol 21:555-64
Mick, Eric; McGough, James; Loo, Sandra et al. (2011) Genome-wide association study of the child behavior checklist dysregulation profile. J Am Acad Child Adolesc Psychiatry 50:807-17.e8
McCracken, James T; Aman, Michael G; McDougle, Christopher J et al. (2010) Possible influence of variant of the P-glycoprotein gene (MDR1/ABCB1) on clinical response to guanfacine in children with pervasive developmental disorders and hyperactivity. J Child Adolesc Psychopharmacol 20:1-5
McGough, James J; McCracken, James T; Loo, Sandra K et al. (2009) A candidate gene analysis of methylphenidate response in attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 48:1155-64
Jahromi, Laudan B; Kasari, Connie L; McCracken, James T et al. (2009) Positive effects of methylphenidate on social communication and self-regulation in children with pervasive developmental disorders and hyperactivity. J Autism Dev Disord 39:395-404

Showing the most recent 10 out of 28 publications